EUVIMEDObjevte EUVIMED
Systematische ÜbersichtUmbrella Review

Berberine and health outcomes: An umbrella review

Zhongyu Li iD, Yang Wang iD, Qing Xu iD, Jinxin Ma iD, Xuan Li iD, Jiaxing Yan iD, Yibing Tian iD, Yandong Wen iD, Ting Chen iD

Phytotherapy Research · 2023-05 · 37 (5) · 2051-2066

DOI: 10.1002/ptr.7806 ↗

At a glance

Systematische Übersicht in Phytotherapy Research, published online on 2023-03-31. Written by Zhongyu Li and 8 co-authors. Institution: Department of Gastroenterology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China. Major MEDLINE topics: Berberine, Colorectal Neoplasms. Cited 106 times so far (Crossref); 61 references. Funded by: National Natural Science Foundation of China, Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Berberine is a plant extract widely used in clinical practice. This review aimed to summarize and to grade the available evidence on the association between berberine consumption and health‐related outcomes. The PubMed, Cochrane Library, and Embase databases were searched for meta‐analyses of randomized controlled trials (RCTs) assessing the efficacy and safety of berberine from inception to June 30, 2022. The AMSTAR‐2 and GRADE system were used to assess the methodological quality and evidence level of the included meta‐analyses. A total of 11 eligible meta‐analyses were identified from 235 publications, which were published in peer‐reviewed journals between 2013 and 2022. The results revealed that berberine significantly affects blood glucose levels, insulin resistance, blood lipids, body parameters and composition, inflammatory markers, colorectal adenomas, and Helicobacter pylori infections as compared to controls. Common side effects of berberine consumption include gastrointestinal symptoms, such as constipation and diarrhea. Berberine is a safe medicinal plant ingredient that improves various clinical outcomes; however, there is a need for improvement of methodological quality in published meta‐analyses. Additionally, the clinical effects of berberine need to be confirmed in high‐quality RCTs.

Subjects

MeSH terms (MEDLINE)

BerberineColorectal NeoplasmsHumansLipidsConstipation

Author keywords

AMSTAR-2berberinehealth outcomesmeta-analysis

Substances

BerberineLipids

Authors and institutions

  • Department of Gastroenterology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Department of Chinese Medicine, Eye Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

ORCID profiles: Zhongyu Li, Yang Wang, Qing Xu, Jinxin Ma, Xuan Li, Jiaxing Yan, Yibing Tian, Yandong Wen, Ting Chen

Funding

  • National Natural Science Foundation of China
  • Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences

Cite

APA

Li, Z., Wang, Y., Xu, Q., Ma, J., Li, X., Yan, J., Tian, Y., Wen, Y., & Chen, T. (2023). Berberine and health outcomes: An umbrella review. Phytotherapy Research, 37(5), 2051-2066. https://doi.org/10.1002/ptr.7806

Vancouver

Li Z, Wang Y, Xu Q, Ma J, Li X, Yan J, et al. Berberine and health outcomes: An umbrella review. Phytotherapy Research. 2023;37(5):2051-2066. doi:10.1002/ptr.7806

BibTeX
@article{Li2023,
  author = {Li, Zhongyu and Wang, Yang and Xu, Qing and Ma, Jinxin and Li, Xuan and Yan, Jiaxing and Tian, Yibing and Wen, Yandong and Chen, Ting},
  title = {Berberine and health outcomes: An umbrella review},
  journal = {Phytotherapy Research},
  year = {2023},
  volume = {37},
  number = {5},
  pages = {2051--2066},
  doi = {10.1002/ptr.7806}
}
Start for free →